Back to Agenda
Aspects for Practical Implementation of the Windsor Framework – Small Pharma and Big Pharma Perspectives
Session Chair(s)
Lauren East
Head, Pharmacovigilance UK
Abbvie, United Kingdom
We will discuss the practical issues that companies need to consider when implementing the Windsor Framework and share preparations being considered and planned by a range of company types.
Speaker(s)
Small Pharma Perspective
Nicola Lawson
Jazz Pharmaceuticals, United Kingdom
Associate Director, EU/Int PV & QPPV Office, PV Intelligence and UK QPPV
Small Pharma Perspective
Deborah Robinson
Jazz Pharmaceuticals, United Kingdom
Senior Manager, Deputy UK QPPV
Big Pharma Perspective
Helen Fiddes
Bristol-Myers Squibb, United Kingdom
Head of Country Pharmacovigilance, UK and Ireland
Have an account?
